Poly (Vinyl Alcohol)/Agar Hydrogel Electrolytes Based Flexible All-in-One Supercapacitors with Conducting Polyaniline/Polypyrrole Electrodes.

The major components of supercapacitor are electrodes and electrolytes which are fabricated using various materials and methods. Hydrogel is one such material that is used in supercapacitors as electrodes and electrolytes or both. Hydrogels are usually described as a soft and porous network of polymer materials that can swell in water because of the hydrophilic nature of its polymer chains, compriseng a 3D structure. It is well known that supercapacitors possess high-power density but low energy density. For enhancing energy density of these electrochemical cells and a boost in its electrochemical performance and specific capacity, binder free conducting polymer hydrogel electrodes have gained immense attention, especially polyaniline (PANI) and polypyrrole (PPy). Therefore, in this work, chemically crosslinked PVA/Agar hydrogel electrolytes have been prepared and employed. Agar has been added in PVA since it is environmentally friendly, biodegradable, and cost-effective natural polymer. Subsequently, the binder free polyaniline/polypyrrole electrodes were grown on the PVA/Agar hydrogel electrolytes to fabricate all-in-one flexible hydrogels. The synthesized hydrogels were characterized using X-ray diffraction (XRD) analysis, Fourier transform infrared (FTIR) analysis, Field emission scanning electron microscope (FESEM) and mechanical studies. Then, the all-in-one flexible supercapacitors were fabricated using the hydrogels. The electrochemical studies such cyclic voltammetry (CV), galvanic charge discharge (GCD), and electrochemical impedance spectroscopy (EIS) studies. The fabricated all-in-one lamination free supercapacitors showed promising results and by comparing all four samples, PAP2 where 5 mL of PVA was used in combination with 3 mL of Agar and 5 mL of PANI and PPy each, exhibited the highest areal capacitance of 750.13 mF/cm2, energy density of 103.02 µWh/cm2, and 497.22 µW/cm2 power density. The cyclic stability study revealed the 149% capacity retention after 15,000 cycles.

Evaluation of Matrix Metalloproteinases, Cytokines and Their Potential Role in the Development of Ovarian Cancer.

BACKGROUND: Ovarian cancer is the 5th most common cause of deaths in the women among gynecological tumors. There are many growing evidences that stress and other behavioral factors may affect cancer progression and patient survival. The purpose of this study is to determine the key role of matrix metalloproteinases (MMPs), and cytokines in the aggregation and progression of ovarian cancer. METHODOLOGY: Stress variables (MDA, AGEs, AOPPs, NO), profile of antioxidants (SOD, Catalase, Vitamin E & A, GSH, GRx, GPx) and inflammatory biomarkers (MMP-9, MMP-2, MMP-11, IL-1α and TNF-α) were biochemically assessed from venous blood of fifty ovarian cancer patients and twenty healthy control subjects. The results of all parameters were analyzed statistically by independent sample t-test. RESULTS: The results of the study demonstrated that the levels of stress variables like MDA (3.38±1.12nmol/ml), AGEs (2.72±0.22 ng/ml), AOPPs (128.48±27.23 ng/ml) and NO (58.71±8.67 ng/ml) were increased in the patients of ovarian cancer as compared to control individuals whereas the profile of antioxidants like SOD, Catalase, Vitamin E, Vitamin A, GSH and GRx were decreased in ovarian cancer patients (0.11±0.08 µg/ml, 2.41±1.01µmol/mol of protein, 0.22±0.04 µg/ml, 45.84±9.07µg/ml, 4.88±1.18µg/ml, 5.33±1.26 µmol/ml respectively). But the level of GPx antioxidant was increased in ovarian cancer patients (6.58±0.21µmol/ml). Moreover the levels of MMP-9 (64.87±5.35 ng/ml), MMP-2 (75.87±18.82 ng/ml) and MMP-11 (63.58±8.48 ng/ml) were elevated in the patients. Similarly, the levels of various cytokines TNF-α and IL-1α were also increased in the patients of ovarian cancer (32.17±3.52 pg/ml and 7.04±0.85 pg/ml respectively). CONCLUSION: MMPs are commonly expressed in ovarian cancer which are potential extrapolative biomarkers and have a major role in metastasis. Due to oxidative stress, different cytokines are released by tumor associated macrophages (TAMs) that result in the cancer progression. Consequently, tissue inhibitors of matrix metalloproteinases (TIMPs) are the valuable therapeutic approaches to complement conservative anticancer strategies.

A Novel Four-Way Complex Variant Translocation Involving Chromosome 46,XY,t(4;9;19;22)(q25:q34;p13.3;q11.2) in a Chronic Myeloid Leukemia Patient.

Philadelphia (Ph) chromosome (9;22)(q34;q11) is well established in more than 90% of chronic myeloid leukemia (CML) patients, and the remaining 5-8% of CML patients show variant and complex translocations, with the involvement of third, fourth, or fifth chromosome other than 9;22. However, in very rare cases, the fourth chromosome is involved. Here, we found a novel case of four-way Ph+ chromosome translocation involving 46,XY,t(4;9;19;22)(q25:q34;p13.3;q11.2) with CML in the chronic phase. Complete blood cell count of the CML patient was carried out to obtain total leukocytes count, hemoglobin, and platelets. Fluorescence in situ hybridization technique was used for the identification of BCR-ABL fusion gene, and cytogenetic test for the confirmation of Ph (9;22)(q34;q11) and the mechanism of variant translocation in the bone marrow. The patient is successfully treated with a dose of 400 mg/day imatinib mesylate (Gleevec). We observed a significant decrease in white blood cell count of 11.7 × 10(9)/L after 48-month follow-up. Patient started feeling better generally. There was a reduction in the swelling of the body, fatigue, and anxiety.